Compare ARK Genomic Revolution ETF (ARKG) vs Enovix Corporation (ENVX) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Enovix Corporation — how do they compare? ARK Genomic Revolution ETF trades at $40.95, while Enovix Corporation trades at $5.19 (market cap $1.14B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Enovix Corporation nearer its low. Which is the better fit depends on your goals.
| ARKG | ENVX | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $15.93 |
52-Week Low | $23.09 | $4.84 |
Market Cap | — | $1.14B |
Enterprise Value | — | $1.15B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
ENVX trades at $5.20, down 3.7% on the day, with a bearish technical signal from moving averages. The company reported Q1 2026 revenue above guidance and an EPS beat of -$0.14 versus -$0.15 expected, but net losses remain substantial at -$156.74M for 2025. Positive developments include the appointment of a former Apple operations leader as COO to scale manufacturing.
The outlook is mixed: strong analyst buy consensus (75%) and a $12.75 price target suggest significant upside, but high cash burn, negative margins, and persistent losses pose substantial execution risks. Investor sentiment hinges on successful production scaling and path to profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Enovix Corporation
Enovix designs and manufactures advanced silicon-anode lithium-ion batteries. Its technology aims to provide high energy density and improved performance for mobile devices and consumer electronics.
Read more on ENVX →
